# YUFLYMA
> **BLA761219** · Biologics License Application · Sponsor: CELLTRION · Approved 2023-05-23
## Drug
- **FDA Application Number:** BLA761219
- **Application type:** Biologics License Application
- **Brand name:** YUFLYMA
- **Generic name:** ADALIMUMAB-AATY
- **Active ingredients:** ADALIMUMAB-AATY
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CELLTRION
- **Manufacturer:** CELLTRION USA, Inc.
- **First approval:** 2023-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761219)
---
*AI Analytics · CC0 1.0*